A hormonal contraceptive approach to reducing breast and ovarian cancer risk: An update

Endocrine-Related Cancer

Volumn 4, Issue 1, 1997, Pages 125-133

  Pike, M C ^a   Daniels, J R ^a   Spicer, D V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; GONADORELIN; LEUPRORELIN; MEDROXYPROGESTERONE ACETATE;

ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; DOSE RESPONSE; ESTROGEN DEFICIENCY; FEMALE; HORMONAL CONTRACEPTION; HORMONE SUBSTITUTION; HUMAN; OVARY CANCER;

EID: 0030982122     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0040125     Document Type: Article

References (21)

1. Bergkvist L, Adami H-O, Persson I, Hoover R & Schairer C 1989 The risk of breast cancer after estrogen and estrogen-progestin replacement. New England Journal of Medicine 321 293-297.
2. Cline JM, Soderqvist G, von Schoultz E, Skoog L & von Schoultz B 1996 Effects of hormone replacement therapy on the mammary gland of postmenopausal cynomolgus macaques. American Journal of Obstetrics and Gynecology 174 93-100.
3. Ettinger B, Selby J, Citron JT, Vangessel A, Ettinger VM & Henderickson MR 1994 Cyclic hormone replacement therapy using quarterly progestin. Obstetrics and Gynecology 83 693-700.
4. Feig SA 1994 Hormonal reduction of mammographic densities: potential effects on breast cancer risk and performance of diagnostic and screening mammography. Journal of the National Cancer Institute 86 408-409.
5. Feinleib M 1968 Breast cancer and artificial menopause: a cohort study. Journal of the National Cancer Institute 41 315-329.
6. Hirayama T & Wynder EL 1962 A study of the epidemiology of cancer of the breast. II. The influence of hysterectomy. Cancer 15 28-38.
7. Kelsey JL 1979 A review of the epidemiology of human breast cancer. Epidemiologic Reviews 1 74-109.
8. Laidlaw IJ, Clarke RB, Howell A, Owen AWMC, Potten CS & Anderson E 1995 The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology 136 164-171.
9. Lilienfeld AM 1956 The relationship of cancer of the female breast to artificial menopause and marital status. Cancer 9 927-934.
10. Persson I, Yuen J, Bergkvist L, Adami H-O, Hoover R & Schairer C 1992 Combined oestrogen-progestogen replacement and breast cancer risk. Lancet 340 1044.
11. Pike MC 1987 Age-related factors in cancer of the breast, ovary and endometrium. Journal of Chronic Diseases 40 59-69.
12. Pike MC, Krailo MD, Henderson BE, Casagrande JT & Hoel DG 1983 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature 303 767-770.
13. Pike MC, Ross RK, Lobo RA, Key TJA, Potts M & Henderson BE 1989 LHRH agonists and the prevention of breast and ovarian cancer. British Journal of Cancer 60 142-148.
14. Pike MC, Bernstein L & Spicer DV 1993a Exogenous hormones and breast cancer risk. In Current Therapy in Oncology. Ed JE Niederhuber. St Louis: B C Decker, Mosby Year Book Inc.
15. Pike MC, Spicer DV, Dahmoush L & Press MF 1993b Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiologic Reviews 15 17-35.
16. Pike MC, Ursin G & Spicer DV 1996 Experiments on proliferation of normal human breast tissue in nude mice do not show that progesterone does not stimulate breast cells. Endocrinology 137 1.
17. Spicer DV, Shoupe D & Pike MC 1991 GnRH agonists as contraceptive agents: predicted significantly reduced risk of breast cancer. Contraception 44 289-310.
18. Spicer DV, Pike MC, Pike A, Rude R, Shoupe D & Richardson J 1993 Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer. Contraception 47 427-444.
19. Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A & Pike MC 1994 Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. Journal of the National Cancer Institute 86 431-436.
20. Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, Flanders WD & Berkelman RL 1991 A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. Journal of the American Medical Association 265 1985-1900.
21. Trichopoulos DB, MacMahon B & Cole P 1972 Menopause and breast cancer risk. Journal of the National Cancer Institute 48 605-613.